|
|
|
|
 |
|
Welcome to

Stem Cell Research News
If your professional life requires reliable,
independent intelligence on stem cell research developments, you should
subscribe today to Stem Cell Research News, published biweekly
since October 1999!
Biweekly;
12-16 pages;
PDF only via e-mail
Corporate, non-profit and individual
rates available. (See below.)
|


Nonprofit, for-profit and personal (individual) subscriptions available
(scroll down this page).
Includes access to all premium content on StemCellResearchNews.com. |
Founded in October 1999, Stem Cell Research News
is the only independent biweekly report that
provides in-depth detail on basic (preclinical) research, therapeutic
development, clinical trials, etc. -- all the latest findings,
plus U.S. and global policymaking activities affecting stem
cell research.
You
need to stay in close touch with developments affecting
federal stem cell research funding policies. Stem Cell
Research News will be there every step of the way.
Subscribe today! |
|
Examine a sample issue:
Click here. NOTE: To view this PDF file you will need Adobe Acrobat
Reader. To download and install this free view software, click on the
Adobe icon.

Subscription options:
- For-profit rate: $345.00.
PDF via e-mail. This is the basic rate for public and private companies.
- Nonprofit rate:
$269.00.
PDF. Special rate for schools, hospitals, government agencies, nonprofit
organizations, etc.
- Individual rate:
$99.00. PDF. For
students, patients, and patients' families.
NOT for employees of any institution performing
stem cell research or doing business of any kind for or
with an organization performing stem cell research.
To choose one of these options,
all of which include free access to archived articles,
click here. Your
subscription order will be processed through Google Checkout and will
require a quick and simple activation of a Google Checkout account.
Subscribe to both Stem Cell Research News AND
Stem Cell Business News at the same time! Save $100 on both
subscriptions together.
Click here [link temporarily inactive] to order.
|
|
|
 |